Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis

EJ Mills, E Druyts, I Ghement, MA Puhan - Clinical epidemiology, 2011 - Taylor & Francis
Background: Most patients with moderate and severe chronic obstructive pulmonary disease
(COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however …
被引用次数：91 相关文章
[PDF] academia.edu

[PDF][PDF] Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis

EJ Mills, E Druyts, MA Puhan - Clinical Epidemiology, 2011 - academia.edu
Background: Most patients with moderate and severe chronic obstructive pulmonary disease
(COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however …
[PDF] semanticscholar.org

[PDF][PDF] Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis

EJ Mills, E Druyts, MA Puhan - Clinical Epidemiology, 2011 - pdfs.semanticscholar.org
Background: Most patients with moderate and severe chronic obstructive pulmonary disease
(COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however …
[PDF] researchgate.net

[PDF][PDF] Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis

EJ Mills, E Druyts, MA Puhan - Clinical Epidemiology, 2011 - researchgate.net
Background: Most patients with moderate and severe chronic obstructive pulmonary disease
(COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however …
[HTML] nih.gov

[HTML][HTML] Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis

EJ Mills, E Druyts, I Ghement, MA Puhan - Clinical Epidemiology, 2011 - ncbi.nlm.nih.gov
Background: Most patients with moderate and severe chronic obstructive pulmonary disease
(COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however …

Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis

EJ Mills, E Druyts, I Ghement… - Clinical Epidemiology, 2011 - search.proquest.com
Background: Most patients with moderate and severe chronic obstructive pulmonary disease
(COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however …

Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis

EJ Mills, E Druyts, I Ghement… - Clinical …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Most patients with moderate and severe chronic obstructive pulmonary disease
(COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however …

Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis

EJ Mills, E Druyts, I Ghement, MA Puhan - Clinical Epidemiology, 2011 - dovepress.com
Background: Most patients with moderate and severe chronic obstructive pulmonary disease
(COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however …

Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis.

EJ Mills, E Druyts, I Ghement, MA Puhan - Clinical Epidemiology, 2011 - europepmc.org
Background Most patients with moderate and severe chronic obstructive pulmonary disease
(COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however …

Pharmacotherapies for chronic obstructive pulmonary disease: A multiple treatment comparison meta-analysis

EJ Mills, E Druyts, I Ghement… - Clinical …, 2011 - pure.johnshopkins.edu
Background: Most patients with moderate and severe chronic obstructive pulmonary disease
(COPD) receive long-acting bronchodilators (LABA) for symptom control. It is, however …